There's really, really good news in Pfizer's announcement that the coronavirus vaccine it has been developing has turned out to be 90% effective. And that's true even if it turns out that some other company's vaccine becomes the preferred preventative for the coronavirus. That's because of two important facts about the technology involved in Pfizer's […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
